A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer
about
Toward precision medicine of breast cancerDynamic Assessment of Value During High-Cost Cancer Treatment: A Response to American Society of Clinical Oncology and European Society of Medical Oncology.Geographic variation in the intended choice of adjuvant treatments for women diagnosed with screen-detected breast cancer in Queensland.Cost-utility analyses of drug therapies in breast cancer: a systematic review.Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy ReformAssociation Between Histone Methyltransferase hSETD1A and Prognosis in Patients With Triple-Negative Breast Cancer After Surgery: A Retrospective Study in the Chinese Female Population.Sulfated polysaccharide-protein complex sensitizes doxorubicin-induced apoptosis of breast cancer cells in vitro and in vivo.Adjuvant Radiotherapy in Early-Stage Breast Cancer: Evidence-Based Options.Reviewing the quality, health benefit and value for money of chemotherapy and targeted therapy for metastatic breast cancerImpact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC Study.Synthesis and Evaluation of Novel Erlotinib-NSAID Conjugates as More Comprehensive Anticancer Agents.Expression patterns of microRNA-329 and its clinical performance in diagnosis and prognosis of breast cancer.Patient-derived organoid models help define personalized management of gastrointestinal cancer.Synthesis and Experimental Validation of New Designed Heterocyclic Compounds with Antiproliferative Activity versus Breast Cancer Cell Lines MCF-7 and MDA-MB-231
P2860
Q28073967-4BC69A6B-F93B-414C-8BFE-9D116401969BQ33756769-7573C203-DAD9-455C-9316-7375409BDABEQ35859303-6FF811C3-5AF0-40C9-9744-953C9919D4B7Q36116276-A14012E0-E8DE-43ED-A756-848E1AD2B43AQ36854155-EB17A949-CE4F-4AEF-A35F-C8D6B1345F1EQ36992974-D19F1148-1B76-4AF3-BD85-FAAE9A05C831Q37288019-B53C64A1-813A-4CE8-9A1A-A05F9C847821Q38828194-68D21F74-3362-435A-8260-5CF7F3619A3EQ39423484-4482F49D-51D0-4629-B9D7-ADB2AD68761DQ42697630-5E3B9408-DCFB-47AA-B300-04400B689805Q43226830-A2B4B42E-F62A-442D-BA7A-458C815C92A6Q47097248-3023DD2A-93E9-45A1-8386-E46ABBD251CDQ50010294-BF06E3F3-0140-43DB-97D4-D2525E99B53FQ59145543-3AE4CEA0-6565-41AD-9A5C-4CDD45ABFE31
P2860
A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
A review of systematic reviews ...... eted therapy for breast cancer
@ast
A review of systematic reviews ...... eted therapy for breast cancer
@en
A review of systematic reviews ...... eted therapy for breast cancer
@nl
type
label
A review of systematic reviews ...... eted therapy for breast cancer
@ast
A review of systematic reviews ...... eted therapy for breast cancer
@en
A review of systematic reviews ...... eted therapy for breast cancer
@nl
prefLabel
A review of systematic reviews ...... eted therapy for breast cancer
@ast
A review of systematic reviews ...... eted therapy for breast cancer
@en
A review of systematic reviews ...... eted therapy for breast cancer
@nl
P2093
P2860
P3181
P1476
A review of systematic reviews ...... eted therapy for breast cancer
@en
P2093
Alberto J Montero
Vakaramoko Diaby
P2860
P2888
P3181
P356
10.1007/S10549-015-3383-6
P407
P577
2015-04-19T00:00:00Z
P5875
P6179
1028295700